NO20055230L - HIV-integraseinhibitorer - Google Patents

HIV-integraseinhibitorer

Info

Publication number
NO20055230L
NO20055230L NO20055230A NO20055230A NO20055230L NO 20055230 L NO20055230 L NO 20055230L NO 20055230 A NO20055230 A NO 20055230A NO 20055230 A NO20055230 A NO 20055230A NO 20055230 L NO20055230 L NO 20055230L
Authority
NO
Norway
Prior art keywords
optionally
substituted
multisubstituted
het2
nr8r9
Prior art date
Application number
NO20055230A
Other languages
English (en)
Norwegian (no)
Inventor
Wim Gaston Verschueren
Dominique Louis Nest Surleraux
Frederik Frans Desire Daeyaert
Inge Dierynck
Original Assignee
Tibtec Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibtec Pharmaceuticals Ltd filed Critical Tibtec Pharmaceuticals Ltd
Publication of NO20055230L publication Critical patent/NO20055230L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20055230A 2003-04-28 2005-11-07 HIV-integraseinhibitorer NO20055230L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46598703P 2003-04-28 2003-04-28
EP03101164 2003-04-28
PCT/EP2004/050621 WO2004096807A2 (en) 2003-04-28 2004-04-27 Hiv integrase inhibitors

Publications (1)

Publication Number Publication Date
NO20055230L true NO20055230L (no) 2005-11-07

Family

ID=33420586

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055230A NO20055230L (no) 2003-04-28 2005-11-07 HIV-integraseinhibitorer

Country Status (13)

Country Link
US (1) US20060211724A1 (zh)
EP (1) EP1625130A2 (zh)
KR (1) KR20060006047A (zh)
CN (1) CN1812992A (zh)
AP (1) AP2005003451A0 (zh)
AR (1) AR044518A1 (zh)
AU (1) AU2004234087A1 (zh)
BR (1) BRPI0409873A (zh)
CA (1) CA2522990A1 (zh)
MX (1) MXPA05011726A (zh)
NO (1) NO20055230L (zh)
TW (1) TW200507848A (zh)
WO (1) WO2004096807A2 (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006125048A2 (en) * 2005-05-16 2006-11-23 Gilead Sciences, Inc. Hiv-integrase inhibitor compounds
JP5289046B2 (ja) 2005-05-19 2013-09-11 メルク カナダ インコーポレイテッド Ｅｐ４アンタゴニストとしてのキノリン誘導体
AR057455A1 (es) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
EP1906971A2 (en) * 2005-07-27 2008-04-09 Gilead Sciences, Inc. Antiviral compounds
WO2007076005A2 (en) * 2005-12-21 2007-07-05 Gilead Sciences, Inc. Processes and intermediates useful for preparing integrase inhibitor compounds
US20090306054A1 (en) * 2006-05-16 2009-12-10 Gilead Sciences ,Inc. Integrase inhibitors
EP1916249A1 (en) * 2006-10-10 2008-04-30 LEK Pharmaceuticals D.D. 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents
WO2008112205A1 (en) 2007-03-09 2008-09-18 Renovis, Inc. Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2009067541A2 (en) * 2007-11-20 2009-05-28 Gilead Sciences, Inc. Integrase inhibitors
CN105055432A (zh) 2008-01-25 2015-11-18 奇默里克斯公司 治疗病毒感染的方法
US9249147B2 (en) 2008-03-19 2016-02-02 Chembridge Corporation Tyrosine kinase inhibitors
US8822500B2 (en) 2008-03-19 2014-09-02 Chembridge Corporation Tyrosine kinase inhibitors
CA2718872C (en) 2008-03-19 2016-09-13 Chembridge Corporation Novel tyrosine kinase inhibitors
EP2417140B1 (en) * 2009-04-09 2014-11-26 Boehringer Ingelheim International GmbH Inhibitors of hiv replication
US8283366B2 (en) 2010-01-22 2012-10-09 Ambrilia Biopharma, Inc. Derivatives of pyridoxine for inhibiting HIV integrase
US9006218B2 (en) 2010-02-12 2015-04-14 Chimerix Inc. Nucleoside phosphonate salts
US10513515B2 (en) 2017-08-25 2019-12-24 Biotheryx, Inc. Ether compounds and uses thereof
WO2020023782A1 (en) 2018-07-27 2020-01-30 Biotheryx, Inc. Bifunctional compounds as cdk modulators
WO2021222150A2 (en) 2020-04-28 2021-11-04 Anwita Biosciences, Inc. Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544732B1 (en) * 1999-05-20 2003-04-08 Illumina, Inc. Encoding and decoding of array sensors utilizing nanocrystals
JP2004517860A (ja) * 2000-10-12 2004-06-17 メルク　エンド　カムパニー　インコーポレーテッド Ｈｉｖインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類
US20040157804A1 (en) * 2002-10-16 2004-08-12 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
US7442773B2 (en) * 2004-01-23 2008-10-28 The Board Of Trustees Of The University Of Illinois Universal peptide-binding scaffolds and protein chips

Also Published As

Publication number Publication date
WO2004096807A3 (en) 2005-01-06
MXPA05011726A (es) 2006-01-23
AP2005003451A0 (en) 2005-12-31
TW200507848A (en) 2005-03-01
WO2004096807A2 (en) 2004-11-11
US20060211724A1 (en) 2006-09-21
CN1812992A (zh) 2006-08-02
AU2004234087A1 (en) 2004-11-11
EP1625130A2 (en) 2006-02-15
BRPI0409873A (pt) 2006-05-16
AR044518A1 (es) 2005-09-14
WO2004096807A8 (en) 2005-09-22
KR20060006047A (ko) 2006-01-18
CA2522990A1 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
NO20055230L (no) HIV-integraseinhibitorer
PE20240765A1 (es) Compuestos para la inhibicion de nlrp3 y usos de estos
MA54327B1 (fr) Inhibiteurs de kras g12c
MA45920B1 (fr) Inhibiteurs de pyridopyrimidinone cdk2/4/6
PE20191541A1 (es) Composiciones y metodos para inhibir la accion de la arginasa
MA42292B1 (fr) Dérivés de sulfamoylarylamide cyclisés et leur utilisation à titre de médicaments pour le traitement de l'hépatite b
BRPI0608732A2 (pt) composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto
MA33275B1 (fr) Inhibiteurs de la replication du virus de l'immunodeficience humaine
PE20161247A1 (es) Benzamidas sustituidas y metodos para usarlas
PE20060692A1 (es) Inhibidores bace
MA31763B1 (fr) Inhibiteurs de kinase de type polo
AR065093A1 (es) Compuestos farmacéuticos inhibidores de la biosintesis de leucotrienos
PE20040164A1 (es) Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas
PE20081577A1 (es) Derivados de sulfonamida ciclicos como inhibidores de la recaptacion de monoamina
PE20142098A1 (es) Compuestos terapeuticamente activos y sus metodos de uso
CR9690A (es) 3-acilaminobenzanilidas insecticidas
PE20081448A1 (es) Inhibidores de transcriptasa inversa no nucleosidicos
AR054214A1 (es) Compuestos derivados de 1, 1 - dioxotiadiazina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de la infeccion por el virus de la hepatitis c.
PE20070715A1 (es) Derivados de pirazina
AR051795A1 (es) Derivados de hidantoina inhibidores de metaloproteinasas
AR057072A1 (es) Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
PE20071251A1 (es) Derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
PE20190106A1 (es) Inhibidores del potenciador del homologo zeste 2
EA200970052A1 (ru) 2-(замещенные амино)бензотиазолсульфонамидные ингибиторы вич-протеазы
AR049668A1 (es) Proceso quimico para preparar esteres de 4,4 - difluorometil - 3 - oxo - butanoico por reaccion entre una amida y un ester.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application